Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Diagnosis, Chronic Lymphocytic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00390117
What this trial is testing

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 34
Not applicableStudy completedNCT04964908
What this trial is testing

Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
AstraZeneca 1,088
Early research (Phase 1)Study completedNCT00868413
What this trial is testing

Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
AbbVie (prior sponsor, Abbott) 32
Early research (Phase 1)Study completedNCT01399840
What this trial is testing

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Lymphocytic Leukemia+1 more
Pfizer 33
Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT03425591
What this trial is testing

Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Mantle-Cell
Janssen-Cilag Ltd. 508
Post-approval studies (Phase 4)Study completedNCT01056510
What this trial is testing

MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 357
Testing effectiveness (Phase 2)Ended earlyNCT00265928
What this trial is testing

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Virginia 46
Testing effectiveness (Phase 2)Study completedNCT01066663
What this trial is testing

Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia
Dana-Farber Cancer Institute 20
Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Testing effectiveness (Phase 2)Study completedNCT00096044
What this trial is testing

Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute 45
Early research (Phase 1)WithdrawnNCT03884972
What this trial is testing

Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor

Who this might be right for
Refractory Chronic Lymphocytic LeukemiaRefractory Small Lymphocytic Lymphoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003619
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Drexel University College of Medicine
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Early research (Phase 1)Looking for participantsNCT06547528
What this trial is testing

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

Who this might be right for
Relapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Ono Pharmaceutical Co., Ltd. 108
Not applicableStudy completedNCT04215367
What this trial is testing

Dietary Intervention With High Phenolic EVOO in CLL

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
University of Peloponnese 21
Not applicableStudy completedNCT04774744
What this trial is testing

Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)UnknownNCT00002481
What this trial is testing

Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
St. Luke's Medical Center
Not applicableLooking for participantsNCT06151730
What this trial is testing

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

Who this might be right for
Chronic Lymphocytic LeukemiaHematopoietic and Lymphoid System NeoplasmMantle Cell Lymphoma+2 more
Mayo Clinic 100
Testing effectiveness (Phase 2)Study completedNCT00309881
What this trial is testing

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 75
Next Page